Home
Bio-Engine

Bio-Engine Market Share Analysis for May 2026

上海倍谙基生物科技有限公司是国内首部（2022年）无血清培养基团体标准的制定者，专注为抗体、疫苗和细胞/基因治疗等生物医药企业提供国际品质的高性价比无血清培养基目录化产品、培养基个性化开发以及定制生产等专业技术服务。

Industry: N/A

Domainbio-engine.com.cn

Year Founded2014

Employees51 - 200

Annual Revenue--

Bio-Engine

Bio-Engine (including company regionals)

bio-engine.com.cn

See more website traffic and engagement information

Total visits to Bio-Engine's top domains

Understand Bio-Engine market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

bio-engine.com.cn--

See more with Sales Intelligence

Avg. visit duration in Bio-Engine's top domains

Analyze Bio-Engine engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Bio-Engine's top domains

See how Bio-Engine keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

bio-engine.com.cn--

See more with Sales Intelligence

Bio-Engine top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Bio-Engine

These are the website technologies, by industry, used by Bio-Engine top domains

Advertising (3)

DoubleClick

Conversion & Analytics (2)

Google Analytics

Marketing (1)

Google Marketing Platform

Mobile (1)

Meta Viewport

More Technologies

1

See all

News & Signals from Bio-Engine

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBio Engine launches ultrafeed CHO supplement.BioEngine launches ultrafeed CHO supplement, boosting titers by up to 48%.

NewsBio Engine received financing of $41.8M in Series C on Apr 15th '23.BioEngine announces completion of over 300 million RMB Series C financing round to promote intelligent Manufacturing of the serum-free medium in China.